Ocutra Co 5 mg Eye drops, solution
PDF Leaflet Revision Date: 14 November 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Decrease elevated intraocular pressure in ocular hypertension or open-angle glaucoma.
Dosage (summary)
One drop in the affected eye(s) once daily.
Onset of Action / Duration
Onset: 2 hours, Duration: >24 hours
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; caution in breastfeeding.
Key Drug Interactions
- Oral beta-blockers
- Calcium channel blockers
- Digoxin
Contraindications
- Hypersensitivity to components
- Bronchial asthma
- Severe COPD
- Cardiac failure
Common side effects
- Ocular hyperemia
- Dry eye
- Blurred vision
- Headache
Counselling Points
- Avoid contact with eyelids
- Wait 15 mins before reinserting contact lenses
- Monitor for vision changes
Serious warnings
- Cardiac reactions
- Respiratory reactions
- Anaphylactic reactions
Important Disclaimer
The Ocutra Co 5 mg Eye drops, solution professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
